Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However, this is the opportune time to buy these stocks because they have several years of strong growth in them say Rakesh Jhunjhunwala and Raamdeo Agrawal
Posts tagged GST
Ace Investors Clash Over Impact Of NAMO’s Move To Tax Capital Gains On Shares Even As Novice Investors Tremble In Fright
The Government’s sudden move to levy tax on the capital gains earned by foreign investors investing through Mauritius has sent shockwaves throughout the investing community. While some ace investors have denounced the move as “stupid“, others have lauded it as “sensible“. The conflict of opinion amongst the ace investors has left novice investors in a perplexed state of mind
Re-Rating Is Imminent For Sanjoy Bhattacharyya’s “Solitary Beacon Of Hope” Stock: Motilal Oswal
A specialty chemical stock described by Sanjoy Bhattacharyya as the “solitary beacon of hope” has caught the attention of ace stock pickers. Motilal Oswal has conducted an expert analysis and certified that re-rating is imminent for the stock and that hefty gains can be harvested from it
I Was Bearish, I Am Bearish & I Will Remain Bearish: Saurabh Mukherjea
Saurabh Mukherjea, the whiz-kid from Ambit, is proving to be a tough nut to crack. Despite the general mood of optimism in the economy, he stays adamantly bearish. He has warned that several aspects of the Indian economy are “misfiring” and that one good monsoon will not turn around the Country’s fortunes
Dolly Khanna Teams Up With Kishore Bang & Motilal Oswal To Scoop Up Micro-Cap Pharma Stock
Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead of being a lone wolf, she has relied on the collective wisdom of Kishore Bang and Motilal Oswal to home in on a micro-cap Pharma stock with impressive past performance and ambitious future plans
Daljeet Kohli Condemns Fav Contra Stock Of Sanjoy Bhattacharyya & Saurabh Mukherjea Even As “100 Bagger” Pharma Stock Surges
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing the ignominy of being declared a flop. Luckily, another “100 Bagger” Pharma stock is surging and bringing cheer to investors
Stock Backed By Billionaire Narayana Murthy & Sanjoy Bhattacharyya Is A “Great Investment Opportunity”: Rahul Arora
Rahul Arora of Nirmal Bang has put the spotlight on a top-quality stock backed by visionaries like Billionaire Narayana Murthy & Sanjoy Bhattacharyya. The stock enjoys the unique combination of having high RoE, being debt-free and also offers a high dividend yield
Forget Pharma Stocks. Specialty Chem Stocks Are The New Mega-Baggers: Experts
Leading experts have sent the clarion call that there is a massive opportunity brewing in the specialty chemical space and that early birds stand to make large sums of money. The experts have also short-listed the stocks that are likely to be the big gainers
Four Top-Quality Mid-Cap Stock Picks With Up To 35% Upside By Amar Ambani Of IIFL
Amar Amabani of IIFL has recommended four top-quality mid-cap stocks with the potential of giving gains of up to 35%
Four Reasons To Be “Very Bullish” & “Hugely Optimistic” About India: Goldman Sachs
If you are feeling jittery about India’s growth prospects and NAMO’s ability to deliver on the promised reforms, you have to listen to the cool and confident advice of Katie Koch, top brass at Goldman Sachs. Katie Koch has given convincing reasons why India is the best place to invest in presently as compared to the rest of the World
Recent Comments